
Our February member spotlight shines on the University of Pennsylvania and its technology transfer office, the Penn Center for Innovation (PCI). Celebrating a decade of converting research breakthroughs into practical applications, PCI has facilitated the launch of over 300 startups and executed 7,000+ commercialization agreements. Their efforts have brought numerous inventions to the public eye, as showcased in the PCI Year in Review. Penn’s trailblazing scientists have spearheaded pivotal discoveries benefiting global communities, such as fundamental advances in cell, gene, and nucleic acid therapies. Moving ahead, Penn and PCI remain dedicated to fostering “impact and innovation” amidst the evolving landscape of future technologies.
“As we celebrate ten years of tech transfer at the Penn Center for Innovation, it is important to acknowledge the pivotal role the Bayh-Dole Act has played in transforming our groundbreaking academic research into real-world solutions. New products, services, and companies built on the University’s intellectual property are driving progress in key sectors, including healthcare, AI, robotics, and more. Strong IP rights empower our brilliant researchers to bridge the gap between discovery and impact, allowing their ideas to change lives and shape the future. We look forward to another decade of successful tech transfer and are proud to partner with the Bayh-Dole Coalition in upholding the law that makes it possible.” — Benjamin Dibling, Ph.D., Managing Director, Penn Center for Innovation